Skip to main content

Published locations for Meta-analysis reveals that abrocitinib and upadacitinib top dupilumab in moderate-to-severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Meta-analysis reveals that abrocitinib and upadacitinib top dupilumab in moderate-to-severe atopic dermatitis

User login

  • Reset your password
  • /content/meta-analysis-reveals-abrocitinib-and-upadacitinib-top-dupilumab-moderate-severe-atopic
  • /dermatology/article/263616/atopic-dermatitis/meta-analysis-reveals-abrocitinib-and-upadacitinib-top